A cancer patient from Maryland, Johanna Randow, has initiated legal action against Bard Access Systems, the maker of Bard Infuse-A-Port, alleging that the device malfunctioned and led to a pulmonary embolism by fracturing and sending fragments into her heart.
Bard Infuse-A-Port is designed as an implantable catheter system to facilitate vein access for administering medications, particularly chemotherapy. It consists of a reservoir for medication injection and a silicone or polyurethane catheter positioned within the vein.
Randow’s lawsuit, filed in an Arizona federal court on Sept. 19, is among many others brought against the company, asserting product liability claims due to the device’s alleged defects, which purportedly increase the risk of organ damage, infection, or blood clots.
Chronology of Events:
- Randow received the Bard Infuse-A-Port implant in April 2018 as part of her chemotherapy regimen.
- In July 2019, the port was removed due to malfunctioning.
- Two years later, in November 2021, Randow experienced a pulmonary embolism, with medical examinations revealing a fragmented catheter portion lodged in her heart.
Legal Implications and Injuries:
- Randow’s lawsuit contends that the presence of catheter fragments in her heart poses ongoing health risks and emotional distress.
- Bard PowerPort models faced recalls in March 2020 due to incorrect tunneler tips, while tubing issues, such as cracking and bacterial buildup, have also been reported.
- Complications associated with Bard PowerPort use include abnormal heart rhythms, blood clots, vessel ruptures, and pulmonary embolisms, which can be life-threatening.
- Allegations suggest that Bard Access Systems may have been aware of these issues but failed to adequately address them or inform users.
Legal Recourse and Statute of Limitations:
- Individuals who received Bard PowerPort implants and suffered related injuries, such as blood clots or organ damage, may be eligible to file lawsuits.
- However, there is a statute of limitations for such cases, and individuals beyond this timeframe may be unable to pursue legal action.
In conclusion, the lawsuit filed by Randow against Bard Access Systems underscores the potential risks associated with Bard Infuse-A-Port devices and raises questions about the company’s responsibility to ensure user safety.
